A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).
   Google Scholar   
Citation:
Am J Clin Oncol vol 28 (1) 81-90
Year:
2005
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
Edward F McClay 
Authors:
               
Networks:
 
Study
CALGB-9235
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Aged, Antineoplastic Combined Chemotherapy Protocols, Brain Neoplasms, Carcinoma, Small Cell, Chemotherapy, Adjuvant, Cisplatin, Cranial Irradiation, Dose Fractionation, Etoposide, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasms, Second Primary, Survival Analysis, Tamoxifen